AstraZeneca

242 results

GlaxoSmithKline building in Hounslow, west London: GSK, one of Britain’s two Big Pharma firms, decided to abandon plans for a new manufacturing plant in Ulverston in Cumbria. Photograph: Luke MacGregor GlaxoSmithKline building in Hounslow, west London: GSK, one of Britain’s two Big Pharma firms, decided to abandon plans for a new manufacturing plant in Ulverston in Cumbria. Photograph: Luke MacGregor

In a week when the UK’s Eurosceptic international trade minister Liam Fox suggested the British economy could easily manage without a trade deal with (...)

In a half-year trading update, the construction and infrastructure giant Carillion downgraded its full-year revenue guidance, with sales now expected to be between £4.8 billion and £5 billion. Photograph: PA Wire

Markets were down across the board on Tuesday with defensive stocks driving Britain’s FTSE down while the ISEQ’s drop was driven by significant falls (...)

The New York Stock Exchange. The S&P 500 and the Nasdaq Composite were higher in late morning trading on Friday as technology shares rose and oil prices rebounded from multi-month lows.  Photograph: Michael Nagle/Bloomberg

Another wobble in commodity-related shares and dollar earners put pressure on British blue chips on Friday, underscoring their underperformance agains(...)

Pfizer last year failed in its attempt o buy Allergan and move its headquarters to the Republic. Photograph: Bloomberg

Since becoming chief executive of Pfizer in 2010, Ian Read has twice tried to reshape the drugmaker through a transformational acquisition. And twice (...)

Although shares in Santander fell 0.9 per cent in choppy trade and Banco Popular’s were suspended, Santander said it would buy Popular and carry out a capital increase of around €7 billion.  Photograph: Ron Antonelli/Bloomberg

Banks and utilities supported European stocks on Wednesday, as there was a sense of relief among investors that Spain’s struggling Banco Popular was b(...)

A trial of AstraZeneca’s  drug durvalumab showed it reduced disease progression in lung cancer patients, sending the company’s shares higher. File photograph: Chris Ratcliffe/Bloomberg

A trial of AstraZeneca’s key immunotherapy drug durvalumab showed it reduced disease progression in lung cancer patients, sending the company’s shares(...)

A trader works on the floor of the New York Stock Exchange. Wall Street stocks edged lower in early trading on Friday and were on track to book losses for the week as weak economic data weighed on financial shares. Photograph: Bryan Smith/AFP/Getty Images

European stocks advanced on Friday after their biggest drop since mid-April, as investors searched for fresh triggers for further gains. On Friday, (...)

The company  issued a statement saying the award of a “limited bonus” to Mr Fallon was “in line with the company’s policy”.

Pearson defended its decision to award chief executive John Fallon a 20 per cent pay rise in 2016 as the FTSE 100 education group prepares for a showd(...)

Kingspan chairman Eugene Murtagh and chief financial officer Geoff Doherty: Mr Murtagh’s total pay package increased by 9 per cent last year to €1.915 million. Photograph: Brenda Fitzsimons

The 50 or so shareholders gathered at Kingspan’s annual general meeting in Ballsbridge in Dublin on Thursday had good reason to be cheerful. While sh(...)

Key stock indexes in Europe and on Wall Street climbed on Thursday, but a gauge of global equities was little changed, with gains offset by a decline in emerging markets. Photograph: Getty Images

Global equity markets and the dollar edged higher on Thursday, helped by fresh data showing a tighter US labour market, as investors stayed cautious b(...)

  • « First
  • Prev
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next
  • Last »